243 related articles for article (PubMed ID: 6301800)
1. Review of cannabinoids and their antiemetic effectiveness.
Vincent BJ; McQuiston DJ; Einhorn LH; Nagy CM; Brames MJ
Drugs; 1983 Feb; 25 Suppl 1():52-62. PubMed ID: 6301800
[TBL] [Abstract][Full Text] [Related]
2. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.
Badowski ME
Cancer Chemother Pharmacol; 2017 Sep; 80(3):441-449. PubMed ID: 28780725
[TBL] [Abstract][Full Text] [Related]
3. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
[TBL] [Abstract][Full Text] [Related]
4. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
[TBL] [Abstract][Full Text] [Related]
5. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic Effects of Cannabinoid Agonists in Nonhuman Primates.
Wooldridge LM; Ji L; Liu Y; Nikas SP; Makriyannis A; Bergman J; Kangas BD
J Pharmacol Exp Ther; 2020 Sep; 374(3):462-468. PubMed ID: 32561684
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
Kwiatkowska M; Parker LA; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jul; 174(2):254-9. PubMed ID: 14740147
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid.
Feigenbaum JJ; Richmond SA; Weissman Y; Mechoulam R
Eur J Pharmacol; 1989 Oct; 169(1):159-65. PubMed ID: 2557222
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids in clinical practice.
Williamson EM; Evans FJ
Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
[TBL] [Abstract][Full Text] [Related]
13. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
14. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
15. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
16. Delta-9-tetrahydrocannabinol as an antiemetic.
Anderson PO; McGuire GG
Am J Hosp Pharm; 1981 May; 38(5):639-46. PubMed ID: 6269423
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
[TBL] [Abstract][Full Text] [Related]
18. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.
May MB; Glode AE
Cancer Manag Res; 2016; 8():49-55. PubMed ID: 27274310
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]